(Q50993429)

26 March 2018

title

The scopolamine model as a pharmacodynamic marker in early drug development. (English)

1 reference

26 March 2018

1 reference

1 reference

Robert A Lenz

1

1 reference

26 March 2018

Jeffrey D Baker

2

1 reference

26 March 2018

Charles Locke

3

1 reference

26 March 2018

Lynne E Rueter

4

1 reference

26 March 2018

Eric G Mohler

5

1 reference

26 March 2018

Keith Wesnes

6

1 reference

26 March 2018

Walid Abi-Saab

7

1 reference

26 March 2018

Mario D Saltarelli

8

1 reference

26 March 2018

publication date

8 September 2011

1 reference

26 March 2018

published in

Psychopharmacology

1 reference

26 March 2018

volume

220

1 reference

26 March 2018

issue

1

1 reference

26 March 2018

page(s)

97-107

1 reference

26 March 2018

Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

Effects of intraseptal injection of 192-IgG-saporin in mature and aged Long-Evans rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

Cognitive Enhancing Properties and Tolerability of Cholinergic Agents in Mice: A Comparative Study of Nicotine, Donepezil, and SIB-1553A, a Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

The price of innovation: new estimates of drug development costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

An overview of the tasks used to test working memory in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

Pharmacokinetics and pharmacodynamics of scopolamine after subcutaneous administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

Effects of NMDA Modulation in Scopolamine Dementiaa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

TRH attenuates scopolamine-induced memory impairment in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

Attenuation of pharmacologically-induced attentional impairment by methylphenidate in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

Caffeine attenuates scopolamine-induced memory impairment in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2456-4

Comparative behavioral and neurochemical activities of cholinergic antagonists in rats

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21901320

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00213-011-2456-4

1 reference

26 March 2018

1 reference

26 March 2018